These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 10942043)

  • 1. The brain alpha7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: studies with DMXBA (GTS-21).
    Kem WR
    Behav Brain Res; 2000 Aug; 113(1-2):169-81. PubMed ID: 10942043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxy metabolites of the Alzheimer's drug candidate 3-[(2,4-dimethoxy)benzylidene]-anabaseine dihydrochloride (GTS-21): their molecular properties, interactions with brain nicotinic receptors, and brain penetration.
    Kem WR; Mahnir VM; Prokai L; Papke RL; Cao X; LeFrancois S; Wildeboer K; Prokai-Tatrai K; Porter-Papke J; Soti F
    Mol Pharmacol; 2004 Jan; 65(1):56-67. PubMed ID: 14722237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha7 nicotinic acetylcholine receptor-specific agonist DMXBA (GTS-21) attenuates Aβ accumulation through suppression of neuronal γ-secretase activity and promotion of microglial amyloid-β phagocytosis and ameliorates cognitive impairment in a mouse model of Alzheimer's disease.
    Takata K; Amamiya T; Mizoguchi H; Kawanishi S; Kuroda E; Kitamura R; Ito A; Saito Y; Tawa M; Nagasawa T; Okamoto H; Sugino Y; Takegami S; Kitade T; Toda Y; Kem WR; Kitamura Y; Shimohama S; Ashihara E
    Neurobiol Aging; 2018 Feb; 62():197-209. PubMed ID: 29175709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-[(2,4-Dimethoxy)benzylidene]-anabaseine dihydrochloride protects against 6-hydroxydopamine-induced parkinsonian neurodegeneration through α7 nicotinic acetylcholine receptor stimulation in rats.
    Suzuki S; Kawamata J; Matsushita T; Matsumura A; Hisahara S; Takata K; Kitamura Y; Kem W; Shimohama S
    J Neurosci Res; 2013 Mar; 91(3):462-71. PubMed ID: 23239187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous administration of a selective alpha7 nicotinic partial agonist, DMXBA, improves sensory inhibition without causing tachyphylaxis or receptor upregulation in DBA/2 mice.
    Stevens KE; Cornejo B; Adams CE; Zheng L; Yonchek J; Hoffman KL; Christians U; Kem WR
    Brain Res; 2010 Sep; 1352():140-6. PubMed ID: 20599427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating schizophrenia symptoms with an alpha7 nicotinic agonist, from mice to men.
    Olincy A; Stevens KE
    Biochem Pharmacol; 2007 Oct; 74(8):1192-201. PubMed ID: 17714692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The alpha7 nicotinic receptor agonist 4OH-GTS-21 protects axotomized septohippocampal cholinergic neurons in wild type but not amyloid-overexpressing transgenic mice.
    Ren K; King MA; Liu J; Siemann J; Altman M; Meyers C; Hughes JA; Meyer EM
    Neuroscience; 2007 Aug; 148(1):230-7. PubMed ID: 17640819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia.
    Martin LF; Kem WR; Freedman R
    Psychopharmacology (Berl); 2004 Jun; 174(1):54-64. PubMed ID: 15205879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of benzylidene-anabaseine analogues with agonist and allosteric sites on muscle nicotinic acetylcholine receptors.
    Arias HR; Xing H; Macdougall K; Blanton MP; Soti F; Kem WR
    Br J Pharmacol; 2009 May; 157(2):320-30. PubMed ID: 19338581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of 3-(4-hydroxy, 2-Methoxybenzylidene)anabaseine selectivity and activity at human and rat alpha-7 nicotinic receptors.
    Meyer EM; Kuryatov A; Gerzanich V; Lindstrom J; Papke RL
    J Pharmacol Exp Ther; 1998 Dec; 287(3):918-25. PubMed ID: 9864273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia.
    Olincy A; Harris JG; Johnson LL; Pender V; Kongs S; Allensworth D; Ellis J; Zerbe GO; Leonard S; Stevens KE; Stevens JO; Martin L; Adler LE; Soti F; Kem WR; Freedman R
    Arch Gen Psychiatry; 2006 Jun; 63(6):630-8. PubMed ID: 16754836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GTS-21, a mixed nicotinic receptor agonist/antagonist, does not affect the nicotine cue.
    van Haaren F; Anderson KG; Haworth SC; Kem WR
    Pharmacol Biochem Behav; 1999 Oct; 64(2):439-44. PubMed ID: 10515327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pro-cognitive activity in rats of 3-furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic acetylcholine receptor.
    Potasiewicz A; Kos T; Ravazzini F; Puia G; Arias HR; Popik P; Nikiforuk A
    Br J Pharmacol; 2015 Nov; 172(21):5123-35. PubMed ID: 26276349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive modulation of alpha7 nAChR responses in rat hippocampal interneurons to full agonists and the alpha7-selective partial agonists, 4OH-GTS-21 and S 24795.
    López-Hernández GY; Thinschmidt JS; Morain P; Trocme-Thibierge C; Kem WR; Soti F; Papke RL
    Neuropharmacology; 2009 Mar; 56(4):821-30. PubMed ID: 19705574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha7 receptor-selective agonists and modes of alpha7 receptor activation.
    Papke RL; Meyer E; Nutter T; Uteshev VV
    Eur J Pharmacol; 2000 Mar; 393(1-3):179-95. PubMed ID: 10771012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. alpha7 Nicotinic acetylcholine receptor as a target to rescue deficit in hippocampal LTP induction in beta-amyloid infused rats.
    Chen L; Yamada K; Nabeshima T; Sokabe M
    Neuropharmacology; 2006 Feb; 50(2):254-68. PubMed ID: 16324726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha7 Nicotinic receptor gene delivery into mouse hippocampal neurons leads to functional receptor expression, improved spatial memory-related performance, and tau hyperphosphorylation.
    Ren K; Thinschmidt J; Liu J; Ai L; Papke RL; King MA; Hughes JA; Meyer EM
    Neuroscience; 2007 Mar; 145(1):314-22. PubMed ID: 17218065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzylidene analogs of anabaseine display partial agonist and antagonist properties at the mouse 5-hydroxytryptamine(3A) receptor.
    Machu TK; Hamilton ME; Frye TF; Shanklin CL; Harris MC; Sun H; Tenner TE; Soti FS; Kem WR
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1112-9. PubMed ID: 11714901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity.
    Kihara T; Shimohama S; Sawada H; Kimura J; Kume T; Kochiyama H; Maeda T; Akaike A
    Ann Neurol; 1997 Aug; 42(2):159-63. PubMed ID: 9266724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anabaseine is a potent agonist on muscle and neuronal alpha-bungarotoxin-sensitive nicotinic receptors.
    Kem WR; Mahnir VM; Papke RL; Lingle CJ
    J Pharmacol Exp Ther; 1997 Dec; 283(3):979-92. PubMed ID: 9399967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.